Myelofibrosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GLTO | F | Galecto, Inc. | -2.36 | |
INCY | D | Incyte Corporation | 1.26 | |
KROS | D | Keros Therapeutics, Inc. | 6.08 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 3.66 | |
FBT | D | First Trust Amex Biotech Index Fund | 3.29 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 2.09 | |
XBI | D | SPDR S&P Biotech ETF | 1.83 | |
BBH | B | Market Vectors Biotech ETF | 1.76 |
Compare ETFs
- Myelofibrosis
Primary myelofibrosis is a relatively rare bone marrow cancer. It is currently classified as a myeloproliferative neoplasm, in which the proliferation of an abnormal clone of hematopoietic stem cells in the bone marrow and other sites results in fibrosis, or the replacement of the marrow with scar tissue.The term myelofibrosis alone usually refers to primary myelofibrosis (PMF), also known as chronic idiopathic myelofibrosis (cIMF); the terms idiopathic and primary mean that in these cases the disease is of unknown or spontaneous origin. This is in contrast with myelofibrosis that develops secondary to polycythemia vera or essential thrombocythaemia. Myelofibrosis is a form of myeloid metaplasia, which refers to a change in cell type in the blood-forming tissue of the bone marrow, and often the two terms are used synonymously. The terms agnogenic myeloid metaplasia and myelofibrosis with myeloid metaplasia (MMM) were also used to refer to primary myelofibrosis.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles